APO Research
Talk to an analyst

APO RESEARCH · REPORT

Emphysema Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Emphysema Drug Market Analysis and Forecast 2026-2032

26 December 2025197 pages

Choose your research edition.

Industry ResearchEmphysema Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Emphysema Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Emphysema Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Emphysema Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Emphysema Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Emphysema Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Emphysema Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Emphysema Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Emphysema Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Emphysema Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Emphysema Drug include Angion Biomedica Corp., ProMetic Life Sciences Inc., rEVO Biologics, Inc., SATT North SAS and TGV-Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Emphysema Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Emphysema Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Emphysema Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Emphysema Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Emphysema Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Emphysema Drug sales, projected growth trends, production technology, application and end-user industry.

Emphysema Drug Segment by Company

Angion Biomedica Corp.

ProMetic Life Sciences Inc.

rEVO Biologics, Inc.

SATT North SAS

TGV-Laboratories

Emphysema Drug Segment by Type

MG-53

EDO-66

BB-3

Others

Emphysema Drug Segment by Application

Hospital

Clinic

Others

Emphysema Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emphysema Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Emphysema Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emphysema Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Emphysema Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Emphysema Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Emphysema Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Emphysema Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. MG-53 Major Manufacturers Table 3. EDO-66 Major Manufacturers Table 4. BB-3 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Emphysema Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Emphysema Drug Industry Trends Table 11. Emphysema Drug Industry Drivers Table 12. Emphysema Drug Industry Opportunities and Challenges Table 13. Emphysema Drug Industry Restraints Table 14. Global Emphysema Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Emphysema Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Emphysema Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Emphysema Drug Revenue Market Share by Region (2021-2026) Table 18. Global Emphysema Drug Revenue Market Share by Region (2027-2032) Table 19. Global Emphysema Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 20. Global Emphysema Drug Sales by Region (2021-2026) & (W Units) Table 21. Global Emphysema Drug Sales by Region (2027-2032) & (W Units) Table 22. Global Emphysema Drug Sales Market Share by Region (2021-2026) Table 23. Global Emphysema Drug Sales Market Share by Region (2027-2032) Table 24. Global Emphysema Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Emphysema Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Emphysema Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Emphysema Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Emphysema Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Emphysema Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Emphysema Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Emphysema Drug Manufacturers, Product Type & Application Table 32. Global Emphysema Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Emphysema Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Emphysema Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Emphysema Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Emphysema Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Emphysema Drug Revenue Market Share by Type (2021-2026) Table 39. Global Emphysema Drug Revenue Market Share by Type (2027-2032) Table 40. Global Emphysema Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 41. Global Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 42. Global Emphysema Drug Sales by Type (2027-2032) & (W Units) Table 43. Global Emphysema Drug Sales Market Share by Type (2021-2026) Table 44. Global Emphysema Drug Sales Market Share by Type (2027-2032) Table 45. Global Emphysema Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global Emphysema Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global Emphysema Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Emphysema Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Emphysema Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Emphysema Drug Revenue Market Share by Application (2021-2026) Table 51. Global Emphysema Drug Revenue Market Share by Application (2027-2032) Table 52. Global Emphysema Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 53. Global Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 54. Global Emphysema Drug Sales by Application (2027-2032) & (W Units) Table 55. Global Emphysema Drug Sales Market Share by Application (2021-2026) Table 56. Global Emphysema Drug Sales Market Share by Application (2027-2032) Table 57. Global Emphysema Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Emphysema Drug Price by Application (2027-2032) & (US$/Unit) Table 59. Angion Biomedica Corp. Company Information Table 60. Angion Biomedica Corp. Business Overview Table 61. Angion Biomedica Corp. Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Angion Biomedica Corp. Emphysema Drug Product Portfolio Table 63. Angion Biomedica Corp. Recent Development Table 64. ProMetic Life Sciences Inc. Company Information Table 65. ProMetic Life Sciences Inc. Business Overview Table 66. ProMetic Life Sciences Inc. Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. ProMetic Life Sciences Inc. Emphysema Drug Product Portfolio Table 68. ProMetic Life Sciences Inc. Recent Development Table 69. rEVO Biologics, Inc. Company Information Table 70. rEVO Biologics, Inc. Business Overview Table 71. rEVO Biologics, Inc. Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. rEVO Biologics, Inc. Emphysema Drug Product Portfolio Table 73. rEVO Biologics, Inc. Recent Development Table 74. SATT North SAS Company Information Table 75. SATT North SAS Business Overview Table 76. SATT North SAS Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. SATT North SAS Emphysema Drug Product Portfolio Table 78. SATT North SAS Recent Development Table 79. TGV-Laboratories Company Information Table 80. TGV-Laboratories Business Overview Table 81. TGV-Laboratories Emphysema Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. TGV-Laboratories Emphysema Drug Product Portfolio Table 83. TGV-Laboratories Recent Development Table 84. North America Emphysema Drug Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Emphysema Drug Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 87. North America Emphysema Drug Sales by Type (2027-2032) & (W Units) Table 88. North America Emphysema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 89. North America Emphysema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 90. North America Emphysema Drug Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Emphysema Drug Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 93. North America Emphysema Drug Sales by Application (2027-2032) & (W Units) Table 94. North America Emphysema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 95. North America Emphysema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 96. North America Emphysema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Emphysema Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. North America Emphysema Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. North America Emphysema Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 100. North America Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 101. North America Emphysema Drug Sales by Country (2027-2032) & (W Units) Table 102. North America Emphysema Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 103. North America Emphysema Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 104. United States Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 105. Canada Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 106. Mexico Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 107. Europe Emphysema Drug Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Emphysema Drug Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 110. Europe Emphysema Drug Sales by Type (2027-2032) & (W Units) Table 111. Europe Emphysema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 112. Europe Emphysema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 113. Europe Emphysema Drug Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Emphysema Drug Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 116. Europe Emphysema Drug Sales by Application (2027-2032) & (W Units) Table 117. Europe Emphysema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 118. Europe Emphysema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 119. Europe Emphysema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Emphysema Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. Europe Emphysema Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. Europe Emphysema Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 123. Europe Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 124. Europe Emphysema Drug Sales by Country (2027-2032) & (W Units) Table 125. Europe Emphysema Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 126. Europe Emphysema Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 127. Germany Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 128. France Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 129. U.K. Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 130. Italy Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 131. Russia Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 132. Spain Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 134. Switzerland Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 135. Sweden Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 136. Poland Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 137. China Emphysema Drug Revenue by Type (2021-2026) & (US$ Million) Table 138. China Emphysema Drug Revenue by Type (2027-2032) & (US$ Million) Table 139. China Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 140. China Emphysema Drug Sales by Type (2027-2032) & (W Units) Table 141. China Emphysema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 142. China Emphysema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 143. China Emphysema Drug Revenue by Application (2021-2026) & (US$ Million) Table 144. China Emphysema Drug Revenue by Application (2027-2032) & (US$ Million) Table 145. China Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 146. China Emphysema Drug Sales by Application (2027-2032) & (W Units) Table 147. China Emphysema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 148. China Emphysema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Emphysema Drug Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Emphysema Drug Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 152. Asia Emphysema Drug Sales by Type (2027-2032) & (W Units) Table 153. Asia Emphysema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 154. Asia Emphysema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 155. Asia Emphysema Drug Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Emphysema Drug Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 158. Asia Emphysema Drug Sales by Application (2027-2032) & (W Units) Table 159. Asia Emphysema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 160. Asia Emphysema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Emphysema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Emphysema Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Asia Emphysema Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Asia Emphysema Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 165. Asia Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 166. Asia Emphysema Drug Sales by Country (2027-2032) & (W Units) Table 167. Asia Emphysema Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 168. Asia Emphysema Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 169. Japan Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 170. South Korea Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 171. India Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 172. Australia Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 173. Taiwan Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 174. Southeast Asia Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 175. SAMEA Emphysema Drug Revenue by Type (2021-2026) & (US$ Million) Table 176. SAMEA Emphysema Drug Revenue by Type (2027-2032) & (US$ Million) Table 177. SAMEA Emphysema Drug Sales by Type (2021-2026) & (W Units) Table 178. SAMEA Emphysema Drug Sales by Type (2027-2032) & (W Units) Table 179. SAMEA Emphysema Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 180. SAMEA Emphysema Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 181. SAMEA Emphysema Drug Revenue by Application (2021-2026) & (US$ Million) Table 182. SAMEA Emphysema Drug Revenue by Application (2027-2032) & (US$ Million) Table 183. SAMEA Emphysema Drug Sales by Application (2021-2026) & (W Units) Table 184. SAMEA Emphysema Drug Sales by Application (2027-2032) & (W Units) Table 185. SAMEA Emphysema Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 186. SAMEA Emphysema Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 187. SAMEA Emphysema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Emphysema Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. SAMEA Emphysema Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. SAMEA Emphysema Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 191. SAMEA Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 192. SAMEA Emphysema Drug Sales by Country (2027-2032) & (W Units) Table 193. SAMEA Emphysema Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 194. SAMEA Emphysema Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Brazil Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 196. Argentina Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 197. Chile Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 198. Colombia Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 199. Peru Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 200. Saudi Arabia Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 201. Israel Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 202. UAE Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 203. Turkey Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 204. Iran Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 205. Egypt Emphysema Drug Revenue (2021-2032) & (US$ Million) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Emphysema Drug Distributors List Table 209. Emphysema Drug Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Emphysema Drug Image Figure 2. Global Emphysema Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Emphysema Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. MG-53 Image Figure 5. EDO-66 Image Figure 6. BB-3 Image Figure 7. Others Image Figure 8. Global Emphysema Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Emphysema Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Emphysema Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Emphysema Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Emphysema Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Emphysema Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Emphysema Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Emphysema Drug Sales (2021-2032) & (W Units) Figure 19. Global Emphysema Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 20. Global Emphysema Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Emphysema Drug Sales YoY (2021-2032) & (W Units) Figure 22. Europe Emphysema Drug Sales YoY (2021-2032) & (W Units) Figure 23. China Emphysema Drug Sales YoY (2021-2032) & (W Units) Figure 24. Asia (Excluding China) Emphysema Drug Sales YoY (2021-2032) & (W Units) Figure 25. South America, Middle East and Africa Emphysema Drug Sales YoY (2021-2032) & (W Units) Figure 26. Global Emphysema Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Emphysema Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Emphysema Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Emphysema Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Emphysema Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Emphysema Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 33. Global Emphysema Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Emphysema Drug Sales Market Share by Type (2021-2032) Figure 35. Global Emphysema Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Emphysema Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Emphysema Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Emphysema Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 39. Global Emphysema Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Emphysema Drug Sales Market Share by Application (2021-2032) Figure 41. North America Emphysema Drug Revenue Share by Type (2021-2032) Figure 42. North America Emphysema Drug Sales Share by Type (2021-2032) Figure 43. North America Emphysema Drug Revenue Share by Application (2021-2032) Figure 44. North America Emphysema Drug Sales Share by Application (2021-2032) Figure 45. North America Emphysema Drug Revenue Share by Country (2021-2032) Figure 46. North America Emphysema Drug Sales Share by Country (2021-2032) Figure 47. Europe Emphysema Drug Revenue Share by Type (2021-2032) Figure 48. Europe Emphysema Drug Sales Share by Type (2021-2032) Figure 49. Europe Emphysema Drug Revenue Share by Application (2021-2032) Figure 50. Europe Emphysema Drug Sales Share by Application (2021-2032) Figure 51. Europe Emphysema Drug Revenue Share by Country (2021-2032) Figure 52. Europe Emphysema Drug Sales Share by Country (2021-2032) Figure 53. China Emphysema Drug Revenue Share by Type (2021-2032) Figure 54. China Emphysema Drug Sales Share by Type (2021-2032) Figure 55. China Emphysema Drug Revenue Share by Application (2021-2032) Figure 56. China Emphysema Drug Sales Share by Application (2021-2032) Figure 57. Asia Emphysema Drug Revenue Share by Type (2021-2032) Figure 58. Asia Emphysema Drug Sales Share by Type (2021-2032) Figure 59. Asia Emphysema Drug Revenue Share by Application (2021-2032) Figure 60. Asia Emphysema Drug Sales Share by Application (2021-2032) Figure 61. Asia Emphysema Drug Revenue Share by Country (2021-2032) Figure 62. Asia Emphysema Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Emphysema Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Emphysema Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Emphysema Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Emphysema Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Emphysema Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Emphysema Drug Sales Share by Country (2021-2032) Figure 69. Emphysema Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Emphysema Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • MG-53
  • EDO-66
  • BB-3
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Angion Biomedica Corp.
  • ProMetic Life Sciences Inc.
  • rEVO Biologics, Inc.
  • SATT North SAS
  • TGV-Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Emphysema Drug Market by Type
  3. 1.2.1 Global Emphysema Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 MG-53
  5. 1.2.3 EDO-66
  6. 1.2.4 BB-3
  7. 1.2.5 Others
  8. 1.3 Emphysema Drug Market by Application
  9. 1.3.1 Global Emphysema Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Emphysema Drug Market Dynamics
  1. 2.1 Emphysema Drug Industry Trends
  2. 2.2 Emphysema Drug Industry Drivers
  3. 2.3 Emphysema Drug Industry Opportunities and Challenges
  4. 2.4 Emphysema Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Emphysema Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Emphysema Drug Revenue by Region
  3. 3.2.1 Global Emphysema Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Emphysema Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Emphysema Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Emphysema Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Emphysema Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Emphysema Drug Sales by Region
  9. 3.4.1 Global Emphysema Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Emphysema Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Emphysema Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Emphysema Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Emphysema Drug Revenue by Manufacturers
  2. 4.1.1 Global Emphysema Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Emphysema Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Emphysema Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Emphysema Drug Sales by Manufacturers
  6. 4.2.1 Global Emphysema Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Emphysema Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Emphysema Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Emphysema Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Emphysema Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Emphysema Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Emphysema Drug Manufacturers, Product Type & Application
  13. 4.7 Global Emphysema Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Emphysema Drug Market CR5 and HHI
  16. 4.8.2 2025 Emphysema Drug Tier 1, Tier 2, and Tier 3
5 Emphysema Drug Market by Type
  1. 5.1 Global Emphysema Drug Revenue by Type
  2. 5.1.1 Global Emphysema Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Emphysema Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Emphysema Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Emphysema Drug Sales by Type
  6. 5.2.1 Global Emphysema Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Emphysema Drug Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Emphysema Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Emphysema Drug Price by Type
6 Emphysema Drug Market by Application
  1. 6.1 Global Emphysema Drug Revenue by Application
  2. 6.1.1 Global Emphysema Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Emphysema Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Emphysema Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Emphysema Drug Sales by Application
  6. 6.2.1 Global Emphysema Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Emphysema Drug Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Emphysema Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Emphysema Drug Price by Application
7 Company Profiles
  1. 7.1 Angion Biomedica Corp.
  2. 7.1.1 Angion Biomedica Corp. Company Information
  3. 7.1.2 Angion Biomedica Corp. Business Overview
  4. 7.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Angion Biomedica Corp. Emphysema Drug Product Portfolio
  6. 7.1.5 Angion Biomedica Corp. Recent Developments
  7. 7.2 ProMetic Life Sciences Inc.
  8. 7.2.1 ProMetic Life Sciences Inc. Company Information
  9. 7.2.2 ProMetic Life Sciences Inc. Business Overview
  10. 7.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ProMetic Life Sciences Inc. Emphysema Drug Product Portfolio
  12. 7.2.5 ProMetic Life Sciences Inc. Recent Developments
  13. 7.3 rEVO Biologics, Inc.
  14. 7.3.1 rEVO Biologics, Inc. Company Information
  15. 7.3.2 rEVO Biologics, Inc. Business Overview
  16. 7.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 rEVO Biologics, Inc. Emphysema Drug Product Portfolio
  18. 7.3.5 rEVO Biologics, Inc. Recent Developments
  19. 7.4 SATT North SAS
  20. 7.4.1 SATT North SAS Company Information
  21. 7.4.2 SATT North SAS Business Overview
  22. 7.4.3 SATT North SAS Emphysema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 SATT North SAS Emphysema Drug Product Portfolio
  24. 7.4.5 SATT North SAS Recent Developments
  25. 7.5 TGV-Laboratories
  26. 7.5.1 TGV-Laboratories Company Information
  27. 7.5.2 TGV-Laboratories Business Overview
  28. 7.5.3 TGV-Laboratories Emphysema Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 TGV-Laboratories Emphysema Drug Product Portfolio
  30. 7.5.5 TGV-Laboratories Recent Developments
8 North America
  1. 8.1 North America Emphysema Drug Market Size by Type
  2. 8.1.1 North America Emphysema Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Emphysema Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Emphysema Drug Price by Type (2021-2032)
  5. 8.2 North America Emphysema Drug Market Size by Application
  6. 8.2.1 North America Emphysema Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Emphysema Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Emphysema Drug Price by Application (2021-2032)
  9. 8.3 North America Emphysema Drug Market Size by Country
  10. 8.3.1 North America Emphysema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Emphysema Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Emphysema Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Emphysema Drug Market Size by Type
  2. 9.1.1 Europe Emphysema Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Emphysema Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Emphysema Drug Price by Type (2021-2032)
  5. 9.2 Europe Emphysema Drug Market Size by Application
  6. 9.2.1 Europe Emphysema Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Emphysema Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Emphysema Drug Price by Application (2021-2032)
  9. 9.3 Europe Emphysema Drug Market Size by Country
  10. 9.3.1 Europe Emphysema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Emphysema Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Emphysema Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Emphysema Drug Market Size by Type
  2. 10.1.1 China Emphysema Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Emphysema Drug Sales by Type (2021-2032)
  4. 10.1.3 China Emphysema Drug Price by Type (2021-2032)
  5. 10.2 China Emphysema Drug Market Size by Application
  6. 10.2.1 China Emphysema Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Emphysema Drug Sales by Application (2021-2032)
  8. 10.2.3 China Emphysema Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Emphysema Drug Market Size by Type
  2. 11.1.1 Asia Emphysema Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Emphysema Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Emphysema Drug Price by Type (2021-2032)
  5. 11.2 Asia Emphysema Drug Market Size by Application
  6. 11.2.1 Asia Emphysema Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Emphysema Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Emphysema Drug Price by Application (2021-2032)
  9. 11.3 Asia Emphysema Drug Market Size by Country
  10. 11.3.1 Asia Emphysema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Emphysema Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Emphysema Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Emphysema Drug Market Size by Type
  2. 12.1.1 SAMEA Emphysema Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Emphysema Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Emphysema Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Emphysema Drug Market Size by Application
  6. 12.2.1 SAMEA Emphysema Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Emphysema Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Emphysema Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Emphysema Drug Market Size by Country
  10. 12.3.1 SAMEA Emphysema Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Emphysema Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Emphysema Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Emphysema Drug Value Chain Analysis
  2. 13.1.1 Emphysema Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Emphysema Drug Production Mode & Process
  6. 13.2 Emphysema Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Emphysema Drug Distributors
  9. 13.2.3 Emphysema Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst